Open access · CC-BY
via OpenAlex
Rapamycin not dietary restriction improves resilience against pathogens: a meta-analysis
Eleanor J. Phillips, Mirre J. P. Simons
GeroScience · 2022 · ▲ 22 citations
Abstract
Dietary restriction (DR) and mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) both increase lifespan across a number of taxa. Despite this positive effect on lifespan and other aspects of health, reductions in some physiological functions have been reported for DR, and rapamycin has been used as an immunosuppressant. Perhaps surprisingly, both interventions have been suggested to improve immune function and delay immunosenescence. The immune system is complex and consists of many components. Therefore, arguably, the most holistic measurement of immune function is survival from an acute pathogenic infection. We reanalysed published post-infection short-term survival data of mice (n = 1223 from 23 studies comprising 46 effect sizes involving DR (n = 17) and rapamycin treatment (n = 29) and analysed these results using meta-analysis. Rapamycin treatment significantly increased post infection survival rate (lnHR = - 0.72; CI = - 1.17, -0.28; p = 0.0015). In contrast, DR reduced post-infection survival (lnHR = 0.80; CI = 0.08, 1.52; p = 0.03). Importantly, the overall effect size of rapamycin treatment was significantly lower (p < 0.001) than the estimate from DR studies, suggesting opposite effects on immune function. Our results show that immunomodulation caused by rapamycin treatment is beneficial to the survival from acute infection. For DR, our results are based on a smaller number of studies, but do warrant caution as they indicate possible immune costs of DR. Our quantitative synthesis suggests that the geroprotective effects of rapamycin extend to the immune system and warrants further clinical trials of rapamycin to boost immunity in humans.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1007/s11357-022-00691-4
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
Phillips, E.J., & Simons, M.J.P. (2022). Rapamycin not dietary restriction improves resilience against pathogens: a meta-analysis. <em>GeroScience</em>. https://doi.org/10.1007/s11357-022-00691-4
Vancouver
Phillips EJ, Simons MJP. Rapamycin not dietary restriction improves resilience against pathogens: a meta-analysis. GeroScience. 2022. doi:10.1007/s11357-022-00691-4.
BibTeX
@article{eleanor2022Rapamy,
title = {Rapamycin not dietary restriction improves resilience against pathogens: a meta-analysis},
author = {Eleanor J. Phillips and Mirre J. P. Simons},
journal = {GeroScience},
year = {2022},
doi = {10.1007/s11357-022-00691-4},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature 2013
Preprint
Faculty Opinions recommendation of Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study.
Scientific Reports 2019
Open access · CC-BY
Rapamycin modulates tissue aging and lifespan independently of the gut microbiota in Drosophila
Nutrients 2024
Open access · CC-BY
Time-Restricted Eating and Bone Health: A Systematic Review with Meta-Analysis
Proceedings of the National Academy of Sciences 2008
Preprint · OA
Nrf2 mediates cancer protection but not prolongevity induced by caloric restriction
Aging 2016
Open access · CC-BY
Rapamycin treatment benefits glucose metabolism in mouse models of type 2 diabetes
Peking Union Medical College Hospital 2023
Open access · US-GOV